Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haller

Showing results (511-520 of 526) with videos related to

Pageof 53
Sort By:
Journal of the American College of Cardiology|September 4, 2024
Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AFPaul M Haller, Petr Jarolim, Michael G Palazzolo, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|December 18, 2024
Roadmap for Global Youth Substance Use Prevention, Screening, and Early Intervention ResearchVerena E Metz, Marcus Bendtsen, Sidharth Arya, et al.
European Journal of Preventive Cardiology|June 16, 2026
Early versus delayed evolocumab treatment and complex coronary artery revascularizationPaul M Haller, Prakriti Gaba, Colleen Thomas, et al.
The Lancet. Microbe|February 15, 2025
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled studyMelinda J Hamer, James M McCarty, Benjamin C Pierson, et al.
Vaccine|April 23, 2021
Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccineBenjamin C Pierson, Anthony P Cardile, Arthur C Okwesili, et al.
Journal of the American College of Cardiology|February 18, 2026
Comparison of the European Society of Cardiology 0/1-Hour and High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome 0/2-or-0/3-Hour Algorithms for Rapid Myocardial Infarction Diagnosis: A Prospective Multicenter StudyJonas Glaeser, Pedro Lopez-Ayala, Caroline Kellner, et al.
The Canadian Journal of Cardiology|April 30, 2026
External validation of a universal laboratory pathway for early risk-stratification of myocardial infarction in the emergency settingPeter A Kavsak, John W Pickering, Bianca Strauß, et al.
Journal of the American College of Cardiology|August 27, 2025
A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular RiskPaul M Haller, Giorgio E M Melloni, David D Berg, et al.
Journal of Orthopaedic Trauma|July 26, 2023
Postfasciotomy Classification System for Acute Compartment Syndrome of the LegYasser Bouklouch, Mitchell Bernstein, Michael Bosse, et al.
European Journal of Preventive Cardiology|April 20, 2023
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitusPaul M Haller, Alina Goßling, Christina Magnussen, et al.
Pageof 53

Showing results (511-520 of 526) with videos related to

Sort By:
Pageof 53
Journal of the American College of Cardiology|September 4, 2024
Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AFPaul M Haller, Petr Jarolim, Michael G Palazzolo, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|December 18, 2024
Roadmap for Global Youth Substance Use Prevention, Screening, and Early Intervention ResearchVerena E Metz, Marcus Bendtsen, Sidharth Arya, et al.
European Journal of Preventive Cardiology|June 16, 2026
Early versus delayed evolocumab treatment and complex coronary artery revascularizationPaul M Haller, Prakriti Gaba, Colleen Thomas, et al.
The Lancet. Microbe|February 15, 2025
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled studyMelinda J Hamer, James M McCarty, Benjamin C Pierson, et al.
Vaccine|April 23, 2021
Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccineBenjamin C Pierson, Anthony P Cardile, Arthur C Okwesili, et al.
Journal of the American College of Cardiology|February 18, 2026
Comparison of the European Society of Cardiology 0/1-Hour and High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome 0/2-or-0/3-Hour Algorithms for Rapid Myocardial Infarction Diagnosis: A Prospective Multicenter StudyJonas Glaeser, Pedro Lopez-Ayala, Caroline Kellner, et al.
The Canadian Journal of Cardiology|April 30, 2026
External validation of a universal laboratory pathway for early risk-stratification of myocardial infarction in the emergency settingPeter A Kavsak, John W Pickering, Bianca Strauß, et al.
Journal of the American College of Cardiology|August 27, 2025
A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular RiskPaul M Haller, Giorgio E M Melloni, David D Berg, et al.
Journal of Orthopaedic Trauma|July 26, 2023
Postfasciotomy Classification System for Acute Compartment Syndrome of the LegYasser Bouklouch, Mitchell Bernstein, Michael Bosse, et al.
European Journal of Preventive Cardiology|April 20, 2023
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitusPaul M Haller, Alina Goßling, Christina Magnussen, et al.
Pageof 53